November 7, 2024
TOPLINE: Luminopia, a software system approved by the US Food and Drug Administration to treat amblyopia by modifying TV shows and movies in virtual reality (VR) […]
November 5, 2024
TOPLINE: Only a small proportion of patients with diabetes have undergone artificial intelligence (AI)–based screening for diabetic retinopathy since 2021, despite approval from the US Food […]
November 5, 2024
TOPLINE: Masking during intravitreal anti-VEGF injections was associated with a similar incidence of endophthalmitis compared to not masking, in a large retrospective study. After adjusting for […]
November 4, 2024
CHICAGO — A real-world study of the ocular side effects of the gynecological cancer treatment mirvetuximab (Elahere) has found more than two of three women taking […]
November 1, 2024
BERLIN — Technological advancements and the development of intraocular lenses (IOLs) have significantly improved the care of patients with cataracts, especially for those who would prefer […]
October 30, 2024
A proposal to close the National Eye Institute (NEI) and consolidate it with two other arms of the US National Institutes of Health (NIH) has brought […]
October 22, 2024
TOPLINE: Patients with dry eye disease are more than three times as likely to have mental health conditions, such as depression and anxiety, as those without […]
October 22, 2024
CHICAGO — A post-market study of the retina drug faricimab that enrolled only minority populations historically underrepresented in drug clinical trials found Hispanic and Latino patients […]
October 21, 2024
TOPLINE: In 2022, an estimated 4.22 million US adults had glaucoma and nearly 1.5 million of them experienced some vision loss as a result, with notable […]